62 related articles for article (PubMed ID: 25634795)
1. Retention of platinum sensitivity till late stages of tumour progression may imply improved prognosis of oesophageal and gastric cancers.
Hingorani M; Dixit S; Roy R; Maraveyas A
Oncol Res Treat; 2015; 38(1-2):28-34. PubMed ID: 25634795
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy.
Zhang J; Fan M; Xie J; Wang Z; Wang B; Zhang S; Wang L; Cao J; Tao Z; Li T; Hu X
Oncotarget; 2015 Dec; 6(40):43135-43. PubMed ID: 26447756
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis.
Jo JC; Lee JL; Ryu MH; Sym SJ; Lee SS; Chang HM; Kim TW; Lee JS; Kang YK
Jpn J Clin Oncol; 2007 Dec; 37(12):936-41. PubMed ID: 18211985
[TBL] [Abstract][Full Text] [Related]
5. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
[TBL] [Abstract][Full Text] [Related]
6. Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.
Lorenzen S; Riera Knorrenschild J; Haag GM; Pohl M; Thuss-Patience P; Bassermann F; Helbig U; Weißinger F; Schnoy E; Becker K; Stocker G; Rüschoff J; Eisenmenger A; Karapanagiotou-Schenkel I; Lordick F
Eur J Cancer; 2015 Mar; 51(5):569-76. PubMed ID: 25694417
[TBL] [Abstract][Full Text] [Related]
7. The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Takekuma M; Mori K; Iida T; Kurihara K; Saitou M; Tokunaga H; Kawana K; Ikeda M; Satoh T; Saito T; Miyagi E; Nagai Y; Furusawa A; Kawano Y; Kawano K; Tabata T; Ota Y; Hayase R; Mikami M; Sugiyama T
Cancer Chemother Pharmacol; 2017 Oct; 80(4):697-705. PubMed ID: 28785994
[TBL] [Abstract][Full Text] [Related]
8. Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer.
Hingorani M; Dixit S; Johnson M; Plested V; Alty K; Colley P; Beavis AW; Roy R; Maraveyas A
Cancer Res Treat; 2015 Oct; 47(4):706-17. PubMed ID: 25687854
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of platinum-based chemotherapy in triple-negative breast cancer patients with metastases confined to the lungs: a single-institute experience.
Hong R; Ma F; Xu B; Li Q; Zhang P; Yuan P; Wang J; Fan Y; Cai R
Anticancer Drugs; 2014 Oct; 25(9):1089-94. PubMed ID: 25153786
[TBL] [Abstract][Full Text] [Related]
10. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.
Tortorella L; Langstraat CL; Weaver AL; McGree ME; Bakkum-Gamez JN; Dowdy SC; Cliby WA; Keeney GL; Sherman ME; Weroha SJ; Mariani A; Podratz KC
Gynecol Oncol; 2018 May; 149(2):291-296. PubMed ID: 29550183
[TBL] [Abstract][Full Text] [Related]
11. Brief report: retrospective review of efficacy of erlotinib or gefitinib compared to docetaxel as subsequent line therapy in advanced non-small cell lung cancer (NSCLC) following failure of platinum-based chemotherapy.
Ng R; Loreto M; Lee R; Leighl NB
Lung Cancer; 2008 Aug; 61(2):262-5. PubMed ID: 18358559
[TBL] [Abstract][Full Text] [Related]
12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
13. Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
Powrózek T; Kowalski DM; Krawczyk P; Ramlau R; Kucharczyk T; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Dyszkiewicz W; Krzakowski M; Milanowski J
Clin Lung Cancer; 2014 Nov; 15(6):455-65. PubMed ID: 25246386
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
[TBL] [Abstract][Full Text] [Related]
15. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of platinum analogue-based chemotherapy for advanced esophageal squamous cell carcinoma and prognostic factors].
Yang L; Wang JW; Shi YK
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1233-7. PubMed ID: 21756792
[TBL] [Abstract][Full Text] [Related]
17. Platinum resistance and sensitivity in recurrent/metastatic head and neck squamous cell carcinoma.
Horichi Y; Matsui H; Yamamura Y; Iwae S
Auris Nasus Larynx; 2024 Feb; 51(1):132-137. PubMed ID: 37331819
[TBL] [Abstract][Full Text] [Related]
18. Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.
Kim ST; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
Oncology; 2010; 79(5-6):363-9. PubMed ID: 21430405
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas.
Lo SS; Khorana AA; Javle M; Simon S; Kiefer G; Rajasenan K; Wang H; Hantel A; Shayne M; Hwang J; Schmotzer A; Ramanathan RK
Oncology; 2010; 78(2):125-9. PubMed ID: 20389134
[TBL] [Abstract][Full Text] [Related]
20. Rechallenge with platinum plus fluoropyrimidine +/- epirubicin in patients with oesophagogastric cancer.
Okines AF; Asghar U; Cunningham D; Ashley S; Ashton J; Jackson K; Hawkes E; Chau I
Oncology; 2010; 79(1-2):150-8. PubMed ID: 21150230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
